Cholinergic crisis (myasthenia)
Anticholinesterase excess · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Overtreatment with anticholinesterases in myasthenia causes excess acetylcholine - weakness PLUS muscarinic features (salivation, lacrimation, diarrhoea, bradycardia, miosis, fasciculations) - which can mimic a myasthenic crisis but is the opposite problem. Stopping the drug, supporting the airway and atropine for muscarinic effects are key.
Assessment
Investigations
- Distinguish from myasthenic crisis (cholinergic has muscarinic excess: SLUDGE, miosis, fasciculations)
- Assess respiratory function (FVC)
- Review anticholinesterase dosing
Management
- Stop anticholinesterase medication
- Support the airway and ventilation (monitor FVC)
- Atropine for significant muscarinic symptoms/bradycardia
- Neurology involvement; reassess myasthenia treatment
- ICU if respiratory failure
Drugs & doses
Stop anticholinesterase
Atropine (muscarinic symptoms)
Ventilatory support
Disposition
Neurology/ICU.
Weakness WITH salivation, diarrhoea, miosis and fasciculations in a myasthenic is cholinergic crisis - stop the pyridostigmine, do not give more.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.